Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamine

Journal of Neurochemistry

Volumn 114, Issue 3, 2010, Pages 873-885

  Li, Yan ^a   Cheng, Shu Yuan ^b   Chen, Nianhang ^a   Reith, Maarten E A ^a,c  

^a NEW YORK UNIVERSITY   (United States)

^b JOHN JAY COLLEGE OF CRIMINAL JUSTICE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amphetamine; co immunoprecipitation; dopamine transporter; internalization; mutant transporters; oligomerization

Indexed keywords

AMPHETAMINE; DOPAMINE TRANSPORTER; MUTANT PROTEIN; MYC PROTEIN; DOPAMINE; MACROMOLECULE; MYC PROTEIN, HUMAN;

ARTICLE; BIOTINYLATION; CELL STRAIN HEK293; CONTROLLED STUDY; CROSS LINKING; ENDOCYTOSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNALIZATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; WESTERN BLOTTING; WILD TYPE; BIOLOGICAL MODEL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; GENETICS; MACROMOLECULE; METABOLISM; MUTATION; PHYSIOLOGY; SURFACE PROPERTY;

AMPHETAMINE; CELL LINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENDOCYTOSIS; HUMANS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MODELS, NEUROLOGICAL; MUTATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-MYC; SURFACE PROPERTIES;

EID: 77954344196     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06818.x     Document Type: Article

References (32)

1. Balasubramanian S., Teissere J. A., Raju D. V. Hall R. A. (2004) Hetero-oligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking. J. Biol. Chem. 279, 18840 18850.
2. Berger S. P., Farrell K., Conant D., Kempner E. S. Paul S. M. (1994) Radiation inactivation studies of the dopamine reuptake transporter protein. Mol. Pharmacol. 46, 726 731.
3. Chen N. Reith M. E. (2007) Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells. J. Neurochem. 101, 377 388.
4. Chen N. Reith M. E. A. (2008) Substrates dissociate dopamine transporter oligomers. J. Neurochem. 105, 910 920.
5. Chen N., Ferrer J. V., Javitch J. A. Justice J. B. Jr. (2000) Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter. J. Biol. Chem. 275, 1608 1614.
6. Chen N., Vaughan R. A. Reith M. E. A. (2001) The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis. J. Neurochem. 77, 1116 1127.
7. Chen N., Rickey J., Berfield J. L. Reith M. E. A. (2004a) Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine binding. J. Biol. Chem. 279, 5508 5519.
8. Chen N., Zhen J. Reith M. E. A. (2004b) Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR 12909 and benztropine as opposed to cocaine. J. Neurochem. 89, 853 864.
9. Fiorentini C., Gardoni F., Spano P., Di L. M. Missale C. (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J. Biol. Chem. 278, 20196 20202.
10. Fiorentini C., Busi C., Gorruso E., Gotti C., Spano P. Missale C. (2008) Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization. Mol. Pharmacol. 74, 59 69.
11. Genedani S., Guidolin D., Leo G., Filaferro M., Torvinen M., Woods A. S., Fuxe K., Ferre S. Agnati L. F. (2005) Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers. J. Mol. Neurosci. 26, 177 184.
12. Hastrup H., Karlin A. Javitch J. A. (2001) Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc. Natl Acad. Sci. USA 98, 10055 10060.
13. Hastrup H., Sen N. Javitch J. A. (2003) The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs. J. Biol. Chem. 278, 45045 45048.
14. Kilic F. Rudnick G. (2000) Oligomerization of serotonin transporter and its functional consequences. Proc. Natl Acad. Sci. USA 97, 3106 3111.
15. Kniazeff J., Shi L., Loland C. J., Javitch J. A., Weinstein H. Gether U. (2008) An intracellular interaction network regulates conformational transitions in the dopamine transporter. J. Biol. Chem. 283, 17691 17701.
16. Kocabas A. M., Rudnick G. Kilic F. (2003) Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. J. Neurochem. 85, 1513 1520.
17. Koenig J. A. Edwardson J. M. (1997) Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol. Sci. 18, 276 287.
18. Li L. B., Chen N., Ramamoorthy S., Chi L., Cui X. N., Wang L. C. Reith M. E. A. (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279, 21012 21020.
19. MacKinnon R. (1991) Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature 350, 232 235.
20. Milner H. E., Beliveau R. Jarvis S. M. (1994) The in situ size of the dopamine transporter is a tetramer as estimated by radiation inactivation. Biochim. Biophys. Acta 1190, 185 187.
21. Missale C., Fiorentini C., Busi C., Collo G. Spano P. F. (2006) The NMDA/D1 receptor complex as a new target in drug development. Curr. Top. Med. Chem. 6, 801 808.
22. Ozaslan D., Wang S., Ahmed B. A., Kocabas A. M., McCastlain J. C., Bene A. Kilic F. (2003) Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues. J. Biol. Chem. 278, 43991 44000.
23. Ramsey I. S. DeFelice L. J. (2002) Serotonin transporter function and pharmacology are sensitive to expression level: evidence for an endogenous regulatory factor. J. Biol. Chem. 277, 14475 14482.
24. Rice M. E. Cragg S. J. (2008) Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res. Rev. 58, 303 313.
25. Rothman R. B. Baumann M. H. (2003) Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479, 23 40.
26. Seidel S., Singer E. A., Just H. et al. (2005) Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol. Pharmacol. 67, 140 151.
27. Sitte H. H., Farhan H. Javitch J. A. (2004) Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol. Intervent. 4, 38 47.
28. Sorkina T., Doolen S., Galperin E., Zahniser N. R. Sorkin A. (2003) Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J. Biol. Chem. 278, 28274 28283.
29. Stanasila L., Perez J. B., Vogel H. Cotecchia S. (2003) Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J. Biol. Chem. 278, 40239 40251.
30. Tan M., Walwyn W. M., Evans C. J. Xie C. W. (2009) p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons. J. Biol. Chem. 284, 6270 6281.
31. Torres G. E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W. D. Caron M. G. (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278, 2731 2739.
32. Yamashita A., Singh S. K., Kawate T., Jin Y. Gouaux E. (2005) Crystal structure of a bacterial homologue of Na+/Cl - dependent neurotransmitter transporters. Nature 437, 215 223.